Basit öğe kaydını göster

Combination hyperbaric oxygen and temozolomide therapy in c6 rat glioma model

dc.contributor.authorBOZKURT, Erol Rustu
dc.contributor.authorBilir, Ayhan
dc.contributor.authorKaraca, Ismail
dc.contributor.authorYAGMURLU, Kaan
dc.contributor.authorOZAR, Engin
dc.contributor.authorDAGISTAN, Yasar
dc.contributor.authorToklu, Akin
dc.date.accessioned2021-03-03T16:06:42Z
dc.date.available2021-03-03T16:06:42Z
dc.date.issued2012
dc.identifier.citationDAGISTAN Y., Karaca I., BOZKURT E. R. , OZAR E., YAGMURLU K., Toklu A., Bilir A., "Combination hyperbaric oxygen and temozolomide therapy in c6 rat glioma model", ACTA CIRURGICA BRASILEIRA, cilt.27, sa.6, ss.383-387, 2012
dc.identifier.issn0102-8650
dc.identifier.othervv_1032021
dc.identifier.otherav_427ce488-099a-4b7b-afe1-956562fbf027
dc.identifier.urihttp://hdl.handle.net/20.500.12627/48418
dc.identifier.urihttps://doi.org/10.1590/s0102-86502012000600005
dc.description.abstractPURPOSE: Temozolomide (TMZ) has anti-tumor activity in patients with malignant glioma. Hyperbaric oxygen (HBO) may enhance the efficacy of certain therapies that are limited because of the hypoxic tumor microenvironment. We examined the combined effects of TMZ-HBO in a rat glioma model.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectCerrahi Tıp Bilimleri
dc.subjectCERRAHİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.titleCombination hyperbaric oxygen and temozolomide therapy in c6 rat glioma model
dc.typeMakale
dc.relation.journalACTA CIRURGICA BRASILEIRA
dc.contributor.departmentIstanbul Bakirkoy Mental Health & Neurology Training & Research Hospital , ,
dc.identifier.volume27
dc.identifier.issue6
dc.identifier.startpage383
dc.identifier.endpage387
dc.contributor.firstauthorID43928


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster